Auriküler Vagus Sinir Uyarımının Kişiselleştirilmesi ve Optimizasyonu

Abstract

Vagus sinir uyarımı (VSU), yaklaşık 20 yıldır epilepsi ve depresyon gibi hastalıkların tedavisinde kullanılan ve Amerikan Gıda ve İlaç Dairesi tarafından onaylanmış bir tedavidir. Vagus sinirinin homeostazın sağlanmasında, stresin kontrolünde ve bağışıklık sisteminin düzenlenmesinde rol oynadığı bilinmektedir. VSU elektriksel olarak invazif şekilde boyundan, non-invazif şekilde yine boyundan veya kulaktan yapılabilmektedir. Otonom sinir sistemi aktivitesinin değişken karakterinden dolayı, kişiselleştirilmiş akım parametrelerinin uygulanmasının diğer nöromodülasyon yöntemlerine kıyasla VSU'da daha önemli olduğu görülmektedir. Tedavinin etkinliğini arttırmak ve olası yan etkileri azaltmak amacıyla stimülasyon parametreleri (frekans, süre, atım genişliği vb.) kişiden toplanan verilere göre çevrimiçi olarak kapalı döngü uyarım ile şekillendirilebilir. Kişiye özel stimülasyon parametreleri oluşturmak için bireyden elektroensefalografi, fonksiyonel manyetik rezonans görüntüleme, kalp hızı değişkenliği, nabız, kan basıncı, uyarılmış potansiyel gibi ölçümler sürekli olarak toplanabilir. Uyarım sonucunda bireyde oluşan etkilerin takip edilmesi sayesinde uyarım parametreleri daha net belirlenebilir. Yapay zeka ile optimal stimülasyon parametrelerinin belirlendiği kapalı döngüsel bir VSU yönteminin daha etkili ve güvenli olacağı belirtilebilir. Auriküler VSU alanında loT ve makine öğrenmesi tabanlı medikal teknolojik cihazlar geliştiren VagustimⓇ firması tarafından; her iki kulaktan aynı anda uyarım yapabilen, yukarıda belirtildiği şekilde optimal ve kişiselleştirilmiş stimülasyonu gerçekleştirebilecek bir cihaz üretilmiştir. Mobil uygulama arayüzü ile kontrol edilebilecek olan cihaz, teletıp uygulamalarında olduğu gibi kullanıcının uzaktan takip edilmesine de olanak sağlayacaktır.

Keywords

• Vagus sinir uyarımı
• yapay zeka
• otonom sinir sistemi
• makine öğrenmesi
• kişiselleştirilmiş tıp

Personalization and Optimization of Auricular Vagus Nerve Stimulation

Abstract

Vagus nerve stimulation (VSU) is a treatment approved by the US Food and Drug Administration, which has been used for the treatment of diseases such as epilepsy and depression for nearly 20 years. It is known that the vagus nerve plays a role in maintaining homeostasis, controlling stress and regulating the immune system. VSU can be done electrically invasively from the neck, non-invasively from the neck or ear. Due to the variable character of autonomic nervous system activity, the application of personalized current parameters appears to be more important in VSU compared to other neuromodulation methods. In order to increase the effectiveness of the treatment and reduce the possible side effects, the stimulation parameters (frequency, duration, pulse width, etc.) can be shaped by online closed-loop stimulation according to the data collected from the person. Measurements such as electroencephalography, functional magnetic resonance imaging, heart rate variability, pulse, blood pressure, evoked potential can be continuously collected from the individual to create personalized stimulation parameters. Thanks to the monitoring of the effects on the individual as a result of stimulation, the stimulation parameters can be determined more clearly. It can be stated that a closed-loop VSU method, in which optimal stimulation parameters are determined with artificial intelligence, will be more effective and safe. By VagustimⓇ company, which develops IoT and machine learning-based medical technological devices in the field of auricular VSU; A device that can stimulate both ears at the same time and perform optimal and personalized stimulation as stated above has been produced. The device, which can be controlled with the mobile application interface, will also allow the user to be followed remotely, as in telemedicine applications.

Keywords

• Vagus nerve stimulation
• artificial intelligence
• autonomic nervous system
• machine learning
• personalized medicine

References

1. 1. Ohemeng KK, Parham K. Vagal Nerve Stimulation: Indications, Implantation, and Outcomes. Otolaryngol Clin North Am. 2020 Feb:53(1):127-143.
2. 2. Ekmekçi H, Kaptan H. Vagus Nerve Stimulation. Open Access Maced J MedSci. 2017 May 7;5(3):391-394.
3. 3. Bonaz B, Sinniger V, Pellissier S. Vagus Nerve Stimulation at the Interface of Brain-Gut Interactions. Cold Spring Harb Perspect Med. 2019 Aug 1;9(8):a034199.
4. 4. Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. 2016 Oct 15;594(20):5781-5790.
5. 5. Johnson RL, Wilson CG. A review of vagus nerve stimulation as a therapeutic intervention. J Inflamm Res. 2018 May 16;11:203-213.
6. 6. Breit S, Kupferberg A, Rogler G, Hasler G. Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. Front Psychiatry. 2018 Mar 13;9:44.
7. 7. Capilupi MJ, Kerath SM, Becker LB. Vagus Nerve Stimulation and the Cardiovascular System. Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034173.
8. 8. Farmer AD, Albu-Soda A, Aziz Q. Vagus nerve stimulation in clinical practice. Br J Hosp Med (Lond). 2016 Nov 2:77(11):645-651.

9. 9. Mertens A, Raedt R, Gadeyne S, Carrette E, Boon P, Vonck K. Recent advances in devices for vagus nerve stimulation. Expert Rev Med Devices. 2018 Aug; 15(8):527-539.
10. 10. Ellrich J. Transcutaneous Auricular Vagus Nerve Stimulation. J Clin Neurophysiol. 2019 Nov;36(6):437-442.
11. 11. Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat. 2020Apr;236(4):588-611.
12. 12. Yap JYY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T. Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice. Front Neurosci. 2020 Apr28:14:284.
13. 13. Wang Y, Li SY, WangD, et al. Transcutaneous Auricular Vagus Nerve Stimulation: From Concept to Application. Neurosci Bull. 2020 Dec 23. doi: 10.1007/s12264-020-00619-y.
14. 14. Kaniusas E, Kampusch S, Tittgemeyer M, et al. Current Directions in the Auricular Vagus Nerve Stimulation I - A Physiological Perspective. Front Neurosci. 2019 Aug9;13:854.
15. 15. Kutlu N, Özden AV, Alptekin HK, Alptekin JÕ. The Impact of Auricular Vagus Nerve Stimulation on Pain and Life Quality in Patients with Fibromyalgia Syndrome. Biomed Res Int. 2020 Feb28;2020:8656218.
16. 16. Kaniusas E, Kampusch S, Tittgemeyer M, et al. Current Directions in the Auricular Vagus Nerve Stimulation II - An Engineering Perspective. Front Neurosci. 2019 Jul 24;13:772.
17. 17. Thompson N, Mastitskaya S, Holder D. Avoiding off-target effects in electrical stimulation of the cervical vagus nerve: Neuroanatomical tracing techniques to study fascicular anatomy of the vagus nerve. J Neurosci Methods. 2019 Sep1;325:108325.
18. 18. Plachta DT, Gierthmuehlen M, Cota O,et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects. J NeuralEng. 2014 Jun;11(3):036011.
19. 19. Musselman ED, Pelot NA, Grill WM. Empirically Based Guidelines for Selecting Vagus Nerve Stimulation Parameters in Epilepsy and Heart Failure. Cold Spring Harb Perspect Med. 2019 Jul 1;9(7):a034264.
20. 20. Guiraud D, Andreu D, Bonnet S, et al. Vagus nerve stimulation: state of the art of stimulation and recording strategies to address autonomic function neuromodulation. J Neural Eng. 2016 Aug; 13(4):041002.
21. 21. Boon P, Vonck K, van Rijckevorsel K, et al. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation. Seizure. 2015 Nov; 32:52-61.
22. 22. Cukiert A, Cukiert CM, Mariani PP, Burattini JA. Impact of Cardiac-Based Vagus Nerve Stimulation Closed-Loop Stimulation on the Seizure Outcome of Patients With Generalized Epilepsy: A Prospective, Individual-Control Study. Neuromodulation. 2020 Oct 12. doi: 10.1111/ner. 13290.
23. 23. Tzadok M, Harush A, Nissenkorn A, Zauberman Y, Feldman Z, Ben-Zeev B. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy. Seizure. 2019 Oct; 71:140-144.
24. 24. Xu J, Guo H, Nguyen AT, Lim H, Yang Z. A Bidirectional Neuromodulation Technology for Nerve Recording and Stimulation. Micromachines (Basel). 2018 Oct 23;9(11):538.
25. 25. Anand IS, Konstam MA, KleinHU,et al. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020 Feb;7(1):75-83.
26. 26. Burger AM, D'Agostini M, Verkuil B, Van Diest I. Moving beyond belief: A narrative review of potential biomarkers for transcutaneous vagus nerve stimulation. Psychophysiology. 2020 Jun;57(6):e13571.
27. 27. Mourdoukoutas AP, Truong DQ, Adair DK, Simon BJ, Bikson M. High-resolution Multi-Scale Computational Model for Non-invasive Cervical Vagus Nerve Stimulation. Neuromodulation. 2018 Apr;21(3):261-268.
28. 28. Sun FT, Morrell MJ. Closed-loop neurostimulation: the clinical experience. Neurotherapeutics. 2014 Jul;11(3):553-63.
29. 29. Ugalde HR, Le Rolle V, Bel A, et al. On-off closed-loop control of vagus nerve stimulation for the adaptation of heart rate. Annu Int Conf 2014;2014:6262-5. IEEE Eng Med Biol Soc.
30. 30. Tosato M, Yoshida K, Toft E, Nekrasas V, Struijk JJ. Closed-loop control of the heart rate by electrical stimulation of the vagus nerve. Med Biol Eng Comput. 2006 Mar;44(3):161-9.
31. 31. Romero-Ugalde HM, Le Rolle V, BonnetJL, et al. A novel controller based on state-transition models for closed-loop vagus nerve stimulation: Application to heart rate regulation. PLoSOne. 2017 Oct 27;12(10):e0186068.
32. 32. Romero-Ugalde HM, Le Rolle V, Bonnet JL, Henry C, Mabo P, Carrault G, Hernandez Al. Closed-loop vagus nerve stimulation based on state transition models. IEEE Trans Biomed Eng. 2018 Jul;65(7):1630-1638.
33. 33. Cork SC, Eftekhar A, Mirza KB, et al. Extracellular pH monitoring for use in closed-loop vagus nerve stimulation. J NeuralEng. 2018 Feb;15(1):016001.
34. 34. Mithani K, Mikhail M, Morgan BR, et al. Connectomic Profiling Identifies Responders to Vagus Nerve Stimulation. Ann Neurol. 2019 Nov:86(5):743-753